Wednesday, May 03, 2023 Congratulations to Dr. Anna Spreafico from Princess Margaret Cancer Centre (UHN) who received the Elizabeth Eisenhauer Early Drug Development Young Investigator Award at the CCTG Spring Meeting. The award is presented to a new investigator who has worked at the CCTG Central Office, IND projects, or has contributed significantly to the conduct of an IND trial at a member centre. “I am greatly honored and humbled to receive this prestigious award and recognition. I feel privileged to work with the exemplary CCTG team. I am grateful for the boundless assistance and guidance and forever indebted to my mentors, colleagues and family for the support and commitment over the years. I look forward to current and future collaborations.“ Dr. Spreafico is Assistant Professor at the University of Toronto and Clinician Investigator in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. Her previous training includes a PhD in translational research in the Program for Evaluation of Targeted Therapies at the University of Colorado, USA, and a subspecialty fellowship in experimental therapeutics at the Princess Margaret Cancer Centre. Dr. Spreafico serves as the Head and Neck Medical Oncology Disease Site Lead and Director of the Phase I Drug Development Fellowship at the Princess Margaret Cancer Centre. Dr. Spreafico is a member of the CCTG Head and Neck Disease site Executive Committee. She serves on the US NCI Head and Neck Cancer Steering Committee rare tumor task force, and she is the Co-Chair of the NRG Oncology Recurrent/Metastatic H&N Cancer Working Group. Dr. Spreafico's full-time academic practice and research include early phase clinical trials, with disease-specific interests in skin/melanoma, and head and neck cancers. Her translational research focuses on immuno-oncology-based, microbiome and cancer interception-driven studies leads as PI Canadian Cancer Trial Group, NRG and NCI CTEP early phase investigator-initiated clinical trials.
